First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: FUJIFILM: the story is balanced — Healthcare segment order intake and backlog growth, particularly large CDMO contract wins from major pharmaceutical…
★ Analysts see FY2028 revenue reaching $3.72T — +4.8% growth in a single year.
What Moves the Stock
1Healthcare segment order intake and backlog growth, particularly large CDMO contract wins from major pharmaceutical companies (contract values typically $50-300M over multi-year periods)
2Semiconductor materials revenue tied to global chip production cycles - photoresists, CMP slurries, and polarizing films for display manufacturing track WSTS semiconductor sales with 1-2 quarter lag
3Yen/dollar exchange rate movements (every ¥1 change impacts operating profit by approximately ¥3-4B annually given export-heavy business model)
4Medical systems installed base growth in China and emerging markets, with recurring revenue from consumables representing 30-35% of healthcare segment sales
5Pharmaceutical CDMO capacity utilization rates at Denmark (Hillerød) and US (Texas, North Carolina) facilities - target 80%+ utilization for profitability
6Healthcare segment (~45% of revenue): Medical imaging systems (X-ray, CT, ultrasound), endoscopic equipment, in-vitro diagnostics, pharmaceutical CDMO services for biologics and small molecules
7Materials segment (~25% of revenue): Electronic materials for semiconductor lithography and displays, industrial chemicals, graphic systems, recording media
8Business Innovation segment (~30% of revenue): Office multifunction printers, production printers, document management solutions primarily in Japan and Asia-Pacific
value - Stock trades at 1.0x book value and 9.5x EV/EBITDA despite transformation to higher-margin healthcare/materials mix.
Rising rates have mixed impact: negative for hospital capital equipment purchasing decisions (medical imaging systems are financed over 5-7…
Watch on earnings: Global semiconductor equipment billings (SEMI book-to-bill ratio) as leading indicator for electronic materials demand with 2-3 quarter lag, USD/JPY exchange rate - every ¥1 appreciation impacts operating profit by ¥3-4B annually, China healthcare capex trends and hospital construction activity (medical imaging systems represent 15-20% of healthcare revenue).
One Sentence Summary:
FUJIFILM: the story is balanced — healthcare segment order intake and backlog growth, particularly large cdmo contract wins from major pharmaceutical companies (contract.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.